Literature DB >> 16611076

Epigenetic control using natural products and synthetic molecules.

Takayoshi Suzuki1, Naoki Miyata.   

Abstract

The term "epigenetics" is defined as "heritable changes in gene expression that occur without changes in DNA sequence". Recently, it has been revealed that DNA methylation and histone modifications such as acetylation, methylation and phosphorylation are epigenetic mechanisms according to this definition. In other words, these posttranslational modifications are important factors in determining when and where a gene will be expressed. To date, several enzymes that catalyze DNA or histone modifications have been identified, such as DNA methyltransferases and histone deacetylases. Inhibitors and activators of enzymes controlling epigenetic modifications are considered useful not only as tools for the elucidation of cellular and biological phenomena, but also as therapeutic agents, since disruption of the balance of epigenetic networks is known to cause some disease states such as cancer. In this review, we present natural products and synthetic molecules that inhibit or activate enzymes catalyzing DNA methylation or histone modifications, and discuss the potential of epigenetic therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16611076     DOI: 10.2174/092986706776361067

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  11 in total

1.  Sulforaphane enhances Nrf2 expression in prostate cancer TRAMP C1 cells through epigenetic regulation.

Authors:  Chengyue Zhang; Zheng-Yuan Su; Tin Oo Khor; Limin Shu; Ah-Ng Tony Kong
Journal:  Biochem Pharmacol       Date:  2013-02-14       Impact factor: 5.858

2.  6-alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site.

Authors:  Massimo Ghizzoni; Jiang Wu; Tielong Gao; Hidde J Haisma; Frank J Dekker; Y George Zheng
Journal:  Eur J Med Chem       Date:  2011-11-10       Impact factor: 6.514

Review 3.  Connections between epigenetic gene silencing and human disease.

Authors:  Timothy J Moss; Lori L Wallrath
Journal:  Mutat Res       Date:  2007-01-21       Impact factor: 2.433

4.  Natural products as DNA methyltransferase inhibitors: a computer-aided discovery approach.

Authors:  Jose L Medina-Franco; Fabian López-Vallejo; Dirk Kuck; Frank Lyko
Journal:  Mol Divers       Date:  2010-08-10       Impact factor: 2.943

5.  Hyperactivated NF-{kappa}B and AP-1 transcription factors promote highly accessible chromatin and constitutive transcription across the interleukin-6 gene promoter in metastatic breast cancer cells.

Authors:  'Matladi N Ndlovu; Carine Van Lint; Karlien Van Wesemael; Pieter Callebert; Dany Chalbos; Guy Haegeman; Wim Vanden Berghe
Journal:  Mol Cell Biol       Date:  2009-08-17       Impact factor: 4.272

Review 6.  Dietary phytochemicals as epigenetic modifiers in cancer: Promise and challenges.

Authors:  Eswar Shankar; Rajnee Kanwal; Mario Candamo; Sanjay Gupta
Journal:  Semin Cancer Biol       Date:  2016-04-23       Impact factor: 15.707

7.  Comparative studies of thiol-sensitive fluorogenic probes for HAT assays.

Authors:  Tielong Gao; Chao Yang; Yujun George Zheng
Journal:  Anal Bioanal Chem       Date:  2012-11-09       Impact factor: 4.142

Review 8.  Clinical and experimental applications of sodium phenylbutyrate.

Authors:  Tommaso Iannitti; Beniamino Palmieri
Journal:  Drugs R D       Date:  2011-09-01

9.  From inflammaging to healthy aging by dietary lifestyle choices: is epigenetics the key to personalized nutrition?

Authors:  Katarzyna Szarc vel Szic; Ken Declerck; Melita Vidaković; Wim Vanden Berghe
Journal:  Clin Epigenetics       Date:  2015-03-25       Impact factor: 6.551

10.  Identification of highly selective and potent histone deacetylase 3 inhibitors using click chemistry-based combinatorial fragment assembly.

Authors:  Takayoshi Suzuki; Yuki Kasuya; Yukihiro Itoh; Yosuke Ota; Peng Zhan; Kaori Asamitsu; Hidehiko Nakagawa; Takashi Okamoto; Naoki Miyata
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.